C ortical superficial siderosis (cSS) has recently been recognized as an imaging marker with high prognostic relevance in patients with cerebral amyloid angiopathy (CAA). 1 The presence of cSS is associated with intracranial hemorrhage, 2, 3 transient focal neurological episodes, and cognitive decline. 4 However, little is known about the specificity of this marker. In particular, it remains unknown whether nonamyloid associated small vessel disease (SVD) may also present with cSS.
Patients with CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) develop SVD at young age. Hence, this hereditary disease serves as a model for pure and severe nonamyloidassociated SVD.
The objectives of the current study are (1) to determine whether cSS is also present in SVD types other than CAA and (2) to compare the patterns of SVD tissue lesions in CAA with cSS with those observed in other types of SVD. Therefore, we first determine the prevalence of cSS in patients with CADASIL and a population-based sample. Second, we systematically compare SVD imaging features, that is, cerebral microbleeds (CMB) and white matter hyperintensities (WMH) between CAA with cSS, CADASIL, and populationbased controls.
Methods
Detailed Methods are provided in the online-only Data Supplement.
Subjects
Subjects were drawn from 3 prospective studies: 364 patients with CADASIL from the Paris-Munich study, 5 372 population-based, healthy subjects from the ASPFS (Austrian Stroke Prevention Family Study), 6 and 100 subjects with cSS and possible/probable CAA from the SuSPect-CAA study (NCT01856699).
Magnetic Resonance Imaging

CMB
7 and cSS were identified on T2*-weighted gradient echo images by 2 trained raters (F.A.W. and E.B.). WMH of presumed vascular origin 7 were segmented on fluid-attenauted inversion recovery images. Segmented lesion masks were registered to a common standard space.
Statistical Analysis
Analyses were performed in R (version 3.2.2). Differences in characteristics and SVD lesion load between samples were analyzed using the Kruskal-Wallis test with Dunn post hoc tests (for continuous variables, R package PMCMR) or χ 2 tests with post hoc tests (for categorical variables, R package fifer). To account for multiple comparisons, all P values were Bonferroni corrected. The similarity of the WMH distribution between samples was evaluated by a colocalization analysis using linear correlation on voxel-wise lesion frequencies. 
Results
Demographic, clinical, and magnetic resonance imaging characteristics of the study samples, and the results of group comparisons are presented in the Table. Although patients with CADASIL showed severe SVD imaging features (Table; Figure 1A) , cSS was absent in the entire sample. Only 2 subjects from the population-based sample had cSS. One of them also had a high number of lobar CMB (n=28), suggesting the presence of CAA.
We next compared the spatial distribution of CMB and WMH between samples (Figures 1B and 2) . CMB in CADASIL were predominantly deep and infratentorial. However, among WMH; B) . A, Each sphere represents 1 CMB in the sample. Maps are superimposed onto the T1 standard space template. B, Aside from frequent WMH in the temporal pole in patients with CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy), the overall pattern was comparable between the three samples. CAA indicates cerebral amyloid angiopathy; cSS, cortical superficial siderosis; and PC, population-based controls CADASIL patients with CMB, lobar areas were affected in nearly every second patient and even strictly lobar involvement occurred in 1 of 10 (Table) . For WMH, the colocalization analysis showed that lesion distribution was most similar between CAA with cSS and CADASIL (R 2 =0.68; P<10 -15 ), whereas colocalization was less strong between CAA with cSS and population-based controls (R 2 =0.52; P<10 -15 ) as well as CADASIL and population-based controls (R 2 =0.31; P<10 -15 ).
Discussion
cSS is a frequent finding in patients with histologically proven CAA. 8 The current study demonstrates that cSS is absent in a large cohort of patients with a severe nonamyloid-associated SVD because of CADASIL and exceedingly rare in a population-based sample. Hence, our results indicate that cSS is not a general marker for SVD, but strongly indicative of the presence of CAA. This is in line with a recent study, which found positive amyloid PET in 12 cSS cases. 9 Our findings on the frequency and distribution of both CMB and WMH show a substantial overlap between samples and therefore suggest a limited value of these imaging markers in discriminating different forms of SVD. Of note, this also applies to lobar CMB, which are considered typical for CAA.
It is commonly hypothesized that cSS reflects the result of recurrent focal convexity hemorrhages triggered by vascular amyloid. 1 Recent data from Abeta antibody trials in Alzheimer disease support this hypothesis: Treatment groups developed cSS in a time, dose, and APOE-dependent manner. 10, 11 Our results suggest that these convexity hemorrhages are typically absent in nonamyloid-associated SVD.
Strengths of this study include the prospectively collected data and the large sample sizes in all groups. A potential limitation is the use of different magnetic resonance field strengths (1.5T and 3T), which might have led to an underestimation of CMB on 1.5T scans. Furthermore, study patients were mostly in early-and middle-stage disease, precluding definite conclusions for late stages. Still, the samples were well representative for an outpatient clinic setting, in which cSS can be of high utility.
Conclusions
These findings provide further evidence that cSS is an imaging marker for CAA. Longitudinal data are needed to investigate the value of cSS in therapeutic decision making.
